|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Skeldon SC and Larry Goldenberg S: Bladder
cancer: A portal into mens health. Urol Onco. 33:40–44. 2015.
View Article : Google Scholar
|
|
3
|
Sathe A and Nawroth R: Targeting the
PI3K/AKT/mTOR pathway in bladder cancer. Methods Mol Biol.
1655:335–350. 2018. View Article : Google Scholar
|
|
4
|
Li J, Zi Y, Wang W and Li Y: LncRNA MEG3
inhibits cell proliferation and metastasis in chronic myeloid
leukemia via targeting miR-184. Oncol Res. 26:297–305. 2018.
View Article : Google Scholar
|
|
5
|
Zhang JJ, Wang DD, Du CX and Wang Y: Long
noncoding RNA ANRIL promotes cervical cancer development by acting
as a sponge of miR-186. Oncol Res. May 22–2017.Epub ahead of print.
View Article : Google Scholar
|
|
6
|
Yang M, Zhai X, Ge T, Yang C and Lou G:
miR-181a-5p promotes proliferation and invasion, and inhibits
apoptosis of cervical cancer cells via regulating inositol
polyphosphate-5-phosphatase A (INPP5A). Oncol Res. 26:703–712.
2018. View Article : Google Scholar
|
|
7
|
Wang Y, Li J, Xu C and Zhang X:
MicroRNA-139-5p inhibit cell proliferation and invasion by
targeting RHO-associated coiled-coil containing protein kinase 2 in
ovarian cancer. Oncol Res. Jun 14–2017.Epub ahead of print.
View Article : Google Scholar
|
|
8
|
Liu L, Yu D, Shi H, Li J and Meng L:
Reduced lncRNA aim enhances the malignant invasion of
triple-negative breast cancer cells mainly by activating
Wnt/beta-catenin/mTOR/PI3K signaling. Pharmazie. 72:599–603.
2017.
|
|
9
|
Jia L, Tian Y, Chen Y and Zhang G: The
silencing of LncRNA-H19 decreases chemoresistance of human glioma
cells to temozolomide by suppressing epithelial-mesenchymal
transition via the Wnt/beta-catenin pathway. Onco Targets Ther.
11:313–321. 2018. View Article : Google Scholar :
|
|
10
|
Xie H, Liao X, Chen Z, Fang Y, He A, Zhong
Y, Gao Q, Xiao H, Li J, Huang W and Liu Y: LncRNA MALAT1 inhibits
apoptosis and promotes invasion by antagonizing miR-125b in bladder
cancer cells. J Cancer. 8:3803–3811. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu Y, Deng C, Zhang H, Zhang J, Peng B and
Hu C: Long non-coding RNA XIST promotes cell growth and metastasis
through regulating miR-139-5p mediated Wnt/beta-catenin signaling
pathway in bladder cancer. Oncotarget. 8:94554–94568.
2017.PubMed/NCBI
|
|
12
|
Zhai X and Xu W: Long noncoding RNA ATB
promotes proliferation, migration and invasion in bladder cancer by
suppressing microRNA-126. Oncol Res. Jan 10–2018.Epub ahead of
print. View Article : Google Scholar
|
|
13
|
Wang M, Guo C, Wang L, Luo G, Huang C, Li
Y, Liu D, Zeng F, Jiang G and Xiao X: Long noncoding RNA GAS5
promotes bladder cancer cells apoptosis through inhibiting EZH2
transcription. Cell Death Dis. 9:2382018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Lu C, Xiao M, Jiang F, Qu L and Ni
R: Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and
promotes cell invasion by regulating the epithelial-to-mesenchymal
transition. Biomed Pharmacother. 89:857–863. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang D, Cao C, Liu L and Wu D:
Up-regulation of LncRNA SNHG20 predicts poor prognosis in
hepatocellular carcinoma. J Cancer. 7:608–617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Z, Chen X, Chen P, Yu S, Nie F, Lu B,
Zhang T, Zhou Y, Chen Q, Wei C, et al: Long non-coding RNA SNHG20
promotes non-small cell lung cancer cell proliferation and
migration by epigenetically silencing of P21 expression. Cell Death
Dis. 8:e30922017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li C, Zhou L, He J, Fang XQ, Zhu SW and
Xiong MM: Increased long noncoding RNA SNHG20 predicts poor
prognosis in colorectal cancer. BMC Cancer. 16:6552016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He S, Zhao Y, Wang X, Deng Y, Wan Z, Yao S
and Shen H: Up-regulation of long non-coding RNA SNHG20 promotes
ovarian cancer progression via Wnt/β-catenin signaling. Biosci Rep.
38:2018. View Article : Google Scholar
|
|
19
|
Liu J, Liu L, Wan JX and Song Y: Long
noncoding RNA SNHG20 promotes gastric cancer progression by
inhibiting p21 expression and regulating the GSK-3beta/beta-catenin
signaling pathway. Oncotarget. 8:80700–80708. 2017.PubMed/NCBI
|
|
20
|
Guan YX, Zhang ZM, Chen XZ, Zhang Q, Liu
SZ and Zhang YL: Lnc RNA SNHG20 participated in proliferation,
invasion and migration of breast cancer cells via miR-495. J Cell
Biochem. Dec 13–2017.Epub ahead of print. View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Huang T, Liu HW, Chen JQ, Wang SH, Hao LQ,
Liu M and Wang B: The long noncoding RNA PVT1 functions as a
competing endogenous RNA by sponging miR-186 in gastric cancer.
Biomed Pharmacother. 88:302–308. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xue M, Pang H, Li X, Li H, Pan J and Chen
W: Long noncoding RNA UCA1 promotes bladder cancer cell migration
and invasion via hsa-miR-145/ZEB1/2/FSCN1 pathway. Cancer Sci.
107:18–17. 2016. View Article : Google Scholar
|
|
24
|
Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X,
Wang M, Huang C, Wang L, Zeng F and Jiang G: LncRNA SPRY4-IT1
sponges miR-101-3p to promote proliferation and metastasis of
bladder cancer cells through up-regulating EZH2. Cancer Lett.
388:281–291. 2017. View Article : Google Scholar
|
|
25
|
Maurya SK, Tewari M, Sharma B and Shukla
HS: Expression of procaspase 3 and activated caspase 3 and its
relevance in hormone-responsive gallbladder carcinoma chemotherapy.
Korean J Intern Med. 28:573–578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Guo LC, et al: MicroRNA-16 inhibits
glioma cell growth and invasion through suppression of BCL2 and the
nuclear factor-kappaB1/MMP9 signaling pathway. Cancer Sci.
105:265–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fife CM, McCarroll JA and Kavallaris M:
Movers and shakers: Cell cytoskeleton in cancer metastasis. Br J
Pharmacol. 171:5507–5523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mowers EE, Sharifi MN and Macleod KF:
Functions of autophagy in the tumor microenvironment and cancer
metastasis. FEBS J. 285:1751–1766. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kapoor C, Vaidya S, Wadhwan V, Hitesh,
Kaur G and Pathak A: Seesaw of matrix metalloproteinases (MMPs). J
Cancer Res Ther. 12:28–35. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen CH, Wu JD, Jou YC, Cheng MC, Lin CT,
Chen PC, Tseng YS, Shi CS, Chen SY, Chang DC and Lee YR: The
correlation between TWIST, E-cadherin, and beta-catenin in human
bladder cancer. J BUON. 16:733–737. 2011.
|
|
31
|
Schmitz-Drager BJ, Schulz WA, Jurgens B,
Gerharz CD, van Roeyen CR, Bültel H, Ebert T and Ackermann R: c-myc
in bladder cancer. Clinical findings and analysis of mechanism.
Urol Res. 25(Suppl 1): S45–S49. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mao XW, Xiao JQ, Li ZY, Zheng YC and Zhang
N: Effects of microRNA-135a on the epithelial-mesenchymal
transition, migration and invasion of bladder cancer cells by
targeting GSK3beta through the Wnt/beta-catenin signaling pathway.
Exp Mol Med. 50:e4292018. View Article : Google Scholar
|
|
33
|
Yuan H, Yu S, Cui Y, Men C, Yang D, Gao Z,
Zhu Z and Wu J: Knockdown of mediator subunit Med19 suppresses
bladder cancer cell proliferation and migration by downregulating
Wnt/beta-catenin signalling pathway. J Cell Mol Med. 21:3254–3263.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mao XW, Xiao JQ, Xu G, Li ZY, Wu HF, Li Y,
Zheng YC and Zhang N: CUL4B promotes bladder cancer metastasis and
induces epithelial-to-mesenchymal transition by activating the
Wnt/beta-catenin signaling pathway. Oncotarget. 8:77241–77253.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang
Z, Qiu F and Lin J: miR-144 downregulation increases bladder cancer
cell proliferation by targeting EZH2 and regulating Wnt signaling.
FEBS J. 280:4531–4538. 2013. View Article : Google Scholar
|
|
36
|
Costa VL, Henrique R, Ribeiro FR, Carvalho
JR, Oliveira J, Lobo F, Teixeira MR and Jerónimo C: Epigenetic
regulation of Wnt signaling pathway in urological cancer.
Epigenetics. 5:343–351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu Y, Yu K, Wang G, Zhang D, Shi C, Ding
Y, Hong D, Zhang D, He H, Sun L, et al: Lanatoside C inhibits cell
proliferation and induces apoptosis through attenuating
Wnt/beta-catenin/c-Myc signaling pathway in human gastric cancer
cell. Biochem Pharmacol. 150:280–292. 2018. View Article : Google Scholar : PubMed/NCBI
|
